Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Moving metoprolol to bedtime may ease daytime tiredness for some people because peak drug levels occur during sleep, but the answer depends on several factors, including whether you take immediate-release or extended-release tablets, your blood pressure and heart rate patterns throughout the day, whether you take it with food, and whether another condition is actually driving your fatigue. Nighttime dosing can also bring trade-offs such as vivid dreams, disrupted sleep, or less coverage during the early morning hours when cardiac events are most common, and abruptly stopping or doubling up during a switch can cause dangerous rebound effects. See below for the full details on dosing timing, side effect timelines, and the specific questions to raise with your prescriber before changing anything.
If fatigue is wearing you down and you are not sure whether the medication, your dose timing, or something else entirely is to blame, a few minutes of structured self-assessment can help you walk into that conversation with clear information instead of guesswork. Take a free, instant, online symptom check to see which explanations fit your pattern of tiredness and what next steps make sense for you.
Last reviewed for medical accuracy: 09/14/2026
Metoprolol is a commonly prescribed beta-blocker used to manage high blood pressure, angina, heart rhythm disorders and to improve survival after a heart attack. One of the most frequent side effects people report is fatigue or feeling unusually tired. If you’re wondering whether shifting your metoprolol dose from morning to night could help reduce daytime drowsiness, understanding how this medication works, its dosing options and the potential risks and benefits is key.
Metoprolol blocks beta-1 receptors in the heart, slowing heart rate and lowering blood pressure. It comes in two main forms:
Blood levels of metoprolol peak around 1.5–2 hours after an IR dose and 6–10 hours after an ER dose. The timing of your dose can influence both how well your blood pressure is controlled over 24 hours and how side effects—like fatigue—affect your daily life.
Pros:
Cons:
Pros:
Cons:
Current clinical guidelines do not universally recommend morning vs. evening dosing for all patients on metoprolol. However, several studies and expert reviews highlight:
Chronotherapy Research
Pharmacokinetic Data
Patient-Centered Considerations
Shifting metoprolol to bedtime may help some people feel more alert during the day, but it’s not guaranteed. Here’s what to consider:
Your Current Schedule
– If you’re on once-daily ER metoprolol and still feel tired by mid-morning, moving the dose to bedtime might reduce the overlap between peak drug levels and your most active hours.
Monitoring Blood Pressure
– Check your blood pressure at home several times (upon waking, mid-day, before bed) for a few days on your usual schedule, then repeat after switching to night.
Potential Side Effects
– Watch for morning dizziness, lightheadedness or unusually low readings (for example, systolic below 90 mm Hg).
Sleep Quality and Breathing
– If you have sleep apnea, taking metoprolol at night might worsen breathing events. Discuss this with your sleep specialist or doctor.
Talk to Your Doctor or Cardiologist
Keep a Symptom Diary
Review Your Other Medications
Consider Formulation
Whether you keep your dose in the morning or move it to bedtime, these strategies can help:
Some signs require prompt medical attention:
For non‐urgent symptoms or to better understand what you’re experiencing, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If you’re thinking about altering when you take metoprolol, speak to a doctor to ensure it’s safe for your specific situation. Talk through your symptoms, home blood pressure readings and any other medications you’re on. Changing the timing of this heart-active drug isn’t just a scheduling issue—it’s a medical decision that should be made with professional guidance.
Speak to a doctor about anything that could be life threatening or serious.
(References)
* Grubb BP, Kosinski D, Samoil D, Pothoulakis A, Lorton M, Kip K. Postpartum syncope. Pacing Clin Electrophysiol. 1995 May;18(5 Pt 1):1028-31. doi: 10.1111/j.1540-8159.1995.tb04744.x. PMID: 7659554.
* Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005 Nov 5;366(9497):1622-32. doi: 10.1016/S0140-6736(05)67661-1. PMID: 16271643.
* Goldner JA. Metoprolol-induced visual hallucinations: a case series. J Med Case Rep. 2012 Feb 15;6:65. doi: 10.1186/1752-1947-6-65. Epub 2012 Feb 15. PMID: 22336000; PMCID: PMC3295654.
* García-Ruiz JM, Fernández-Jiménez R, García-Alvarez A, Pizarro G, Galán-Arriola C, Fernández-Friera L, Mateos A, Nuno-Ayala M, Aguero J, Sánchez-González J, García-Prieto J, López-Melgar B, Martínez-Tenorio P, López-Martín GJ, Macías A, Pérez-Asenjo B, Cabrera JA, Fernández-Ortiz A, Fuster V, Ibáñez B. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function. J Am Coll Cardiol. 2016 May 10;67(18):2093-2104. doi: 10.1016/j.jacc.2016.02.050. Epub 2016 Apr 3. PMID: 27052688.
* Beta Adrenergic Blocking Agents. 2012. PMID: 31643457.
* Shah R, Babar A, Patel A, Dortonne R, Jordan J. Metoprolol-Associated Central Nervous System Complications. Cureus. 2020 May 22;12(5):e8236. doi: 10.7759/cureus.8236. Epub 2020 May 22. PMID: 32582495; PMCID: PMC7306637.
* Yadav A, Yadav RK, Neyaz O, Sherin P P S, Gupta A. Postural Orthostatic Tachycardia Syndrome in Spinal Cord Injury. Cureus. 2023 Jun;15(6):e41124. doi: 10.7759/cureus.41124. Epub 2023 Jun 29. PMID: 37519618; PMCID: PMC10382909.
* Seo K, Yamamoto Y, Kirillova A, Kawana M, Yadav S, Huang Y, Wang Q, Lane KV, Pruitt BL, Perez MV, Bernstein D, Wu JC, Wheeler MT, Parikh VN, Ashley EA. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. Circulation. 2023 Nov 21;148(21):1691-1704. doi: 10.1161/CIRCULATIONAHA.123.065017. Epub 2023 Oct 18. PMID: 37850394.
* Zhao X, Liu T, Yang Q, Yang G, Li X, Tang X, Li J, Liang Z, Li A, Zeng L, Wen J, Wang X, Peng L, Wang W, Cai J, Chen Y, Huang M, Li R, Fu R, Zhao L, Li X, Jiang W. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trial. BMC Med. 2025 Jan 29;23(1):56. doi: 10.1186/s12916-025-03892-8. Epub 2025 Jan 29. PMID: 39881316; PMCID: PMC11780824.
* Clemente-Moragón A, Suárez-Barrientos A, Gómez Tech M, López-Palomar Tech LP, Callejas Alejano S, Martínez F, Fernández FJ, Vega MC, Tech AP, Dopazo A, Sánchez-Cabo F, Fuster V, Oliver E, Ibáñez B. Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction. Nat Commun. 2025 Nov 25;16(1):10450. doi: 10.1038/s41467-025-65385-9. Epub 2025 Nov 25. PMID: 41290608; PMCID: PMC12647902.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.